Genome Editing in Germany and Korea

Modern molecular techniques, often referred to as “genome editing”, are currently revolutionizing molecular biology research. Technologies such as CRISPR-Cas9 allow for surprisingly simple, controlled gene modifications that are more efficient than the previously available methods. This opens up a new scope for molecular biological basic research, particularly into organisms that were not previously accessible for molecular genetic purposes, and for elucidating poorly understood gene functions.  It also allows for far-reaching applications, from new options for plant breeding and biotechnology to somatic gene therapy for human genetic diseases. Focused basic research is still necessary. At the same time, a safe and responsible application of genome editing should be ensured respecting the needs of humanity and the environment.

Renowned scientists from Germany and South Korea will address current trends in these fields of research and discuss possible options for future scientific cooperation. Keynotes will be delivered by Prof. Dr. Jin-Soo Kim, Seoul, and Prof. Dr. Emmanuelle Charpentier, Berlin. Dr. Kim will give the morning keynote on Monday, 19 September on “CRISPR RNA-guided genome editing in human stem cells, animals, and plants”. Leopoldina member Dr. Charpentier will give the evening keynote on Monday, 19 September on “CRISPR-CAS9: a game changer in genome engineering: origins and overview”.

KAST and Leopoldina

In May 2012, the German National Academy of Sciences Leopoldina and the Korean Academy of Science and Technology (KAST) signed a Memorandum of Understanding, thus highlighting their strategic partnership. Within the framework of this cooperation agreement, high-profile joint symposia on topics of global relevance are organized on a regular basis.

Image: Sisters of Design – Anja Krämer & Claudia Dölling GbR